메뉴 건너뛰기




Volumn 63, Issue 7, 2011, Pages 976-981

No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy

Author keywords

albumin; binding parameters; co administration; protein binding; valproic acid

Indexed keywords

ALBUMIN; CARBAMAZEPINE; CARNITINE; CLOBAZAM; CLONAZEPAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

EID: 79958039850     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01282.x     Document Type: Article
Times cited : (18)

References (27)
  • 1
    • 0024997911 scopus 로고
    • Established anticonvulsants and treatment of refractory epilepsy
    • DOI 10.1016/0140-6736(90)91886-F
    • Brodie MJ,. Established anticonvulsants and treatment of refractory epilepsy. Lancet 1990; 336: 350-354. (Pubitemid 20264154)
    • (1990) Lancet , vol.336 , Issue.8711 , pp. 350-354
    • Brodie, M.J.1
  • 2
    • 0024988755 scopus 로고
    • Treatment of epilepsy and febrile convulsions in children
    • DOI 10.1016/0140-6736(90)92025-D
    • Rylance GW,. Treatment of epilepsy and febrile convulsions in children. Lancet 1990; 336: 488-491. (Pubitemid 20264225)
    • (1990) Lancet , vol.336 , Issue.8713 , pp. 488-491
    • Rylance, G.W.1
  • 3
    • 0029826744 scopus 로고    scopus 로고
    • The new generation of antiepileptic drugs: Advantages and disadvantages
    • Perucca E,. The new generation of antiepileptic drugs: advantages and disadvantages. Br J Clin Pharmacol 1996; 42: 531-543. (Pubitemid 26385257)
    • (1996) British Journal of Clinical Pharmacology , vol.42 , Issue.5 , pp. 531-543
    • Perucca, E.1
  • 4
    • 28544433841 scopus 로고    scopus 로고
    • Acute hyperammonemic coma with chronic valproic acid therapy
    • DOI 10.1345/aph.1G167
    • Cuturic M, Abramson RK,. Acute hyperammonemic coma with chronic valproic acid therapy. Ann Pharmacother 2005; 39: 2119-2123. (Pubitemid 41745961)
    • (2005) Annals of Pharmacotherapy , vol.39 , Issue.12 , pp. 2119-2123
    • Cuturic, M.1    Abramson, R.K.2
  • 6
    • 0020644555 scopus 로고
    • Plasma protein-bindng and CSF concentrations of valproic acid in man following acute oral dosing
    • Rapeport WG, et al,. Plasma protein-binding and CSF concentrations of valproic acid in man following acute oral dosing. Br J Clin Pharmacol 1983; 16: 365-369. (Pubitemid 13015759)
    • (1983) British Journal of Clinical Pharmacology , vol.16 , Issue.4 , pp. 365-369
    • Rapeport, W.G.1    Mendelow, A.D.2    French, G.3
  • 7
    • 0026769555 scopus 로고
    • Clinical utility of unbound antiepileptic drug blood levels in the management of epilepsy
    • Lenn NJ, Robertson M,. Clinical utility of unbound antiepileptic drug blood levels in the management of epilepsy. Neurology 1992; 42: 988-990.
    • (1992) Neurology , vol.42 , pp. 988-990
    • Lenn, N.J.1    Robertson, M.2
  • 8
    • 0024256069 scopus 로고
    • Clinical pharmacokinetics of valproic acid
    • Zaccara G, et al,. Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet 1988; 15: 367-389.
    • (1988) Clin Pharmacokinet , vol.15 , pp. 367-389
    • Zaccara, G.1
  • 9
    • 0025854599 scopus 로고
    • Nonlinear pharmacokinetics: Clinical implication
    • Ludden TM,. Nonlinear pharmacokinetics: clinical implication. Clin Pharmacokinet 1991; 20: 429-446.
    • (1991) Clin Pharmacokinet , vol.20 , pp. 429-446
    • Ludden, T.M.1
  • 10
    • 0031435886 scopus 로고    scopus 로고
    • Valproic acid-ketoconazole interaction in normal, hypoalbuminemic, and uremic sera: Lack of interaction in uremic serum caused by the presence of inhibitor
    • DOI 10.1097/00007691-199706000-00007
    • Dasgupta A, Luke M,. Valproic acid-ketoconazole interaction in normal, hypoalbuminemic, and uremic sera: lack of interaction in uremic serum caused by the presence of inhibitor. Ther Drug Monit 1997; 19: 281-285. (Pubitemid 28053482)
    • (1997) Therapeutic Drug Monitoring , vol.19 , Issue.3 , pp. 281-285
    • Dasgupta, A.1    Luke, M.2
  • 11
    • 0028355537 scopus 로고
    • Reduced in vitro displacement of valproic acid from protein binding by salicylate in uremic sera compared with normal sera: Role of uremic compounds
    • Dasgupta A, Jacques M,. Reduced in vitro displacement of valproic acid from protein binding by salicylate in uremic sera compared with normal sera. Role of uremic compounds. Am J Clin Pathol 1994; 101: 349-353. (Pubitemid 24089586)
    • (1994) American Journal of Clinical Pathology , vol.101 , Issue.3 , pp. 349-353
    • Dasgupta, A.1    Jacques, M.2
  • 12
    • 0029893728 scopus 로고    scopus 로고
    • Displacement of valproic acid and carbamazepine from protein binding in normal and uremic sera by tolmetin, ibuprofen, and naproxen: Presence of inhibitor in uremic serum that blocks valproic acid-naproxen interactions
    • Dasgupta A, Volk A,. Displacement of valproic acid and carbamazepine from protein binding in normal and uremic sera by tolmetin, ibuprofen, and naproxen: presence of inhibitor in uremic serum that blocks valproic acid-naproxen interactions. Ther Drug Monit 1996; 18: 284-287.
    • (1996) Ther Drug Monit , vol.18 , pp. 284-287
    • Dasgupta, A.1    Volk, A.2
  • 13
    • 0029809522 scopus 로고    scopus 로고
    • Interaction of valproic acid with nonsteroidal antiinflammatory drugs mefenamic acid and fenoprofen in normal and uremic sera: Lack of interaction in uremic sera due to the presence of endogenous factors
    • DOI 10.1097/00007691-199612000-00005
    • Dasgupta A, Emerson L,. Interaction of valproic acid with nonsteroidal antiinflammatory drugs mefenamic acid and fenoprofen in normal and uremic sera: lack of interaction in uremic sera due to the presence of endogenous factors. Ther Drug Monit 1996; 18: 654-659. (Pubitemid 26404569)
    • (1996) Therapeutic Drug Monitoring , vol.18 , Issue.6 , pp. 654-659
    • Dasgupta, A.1    Emerson, L.2
  • 14
    • 0031886111 scopus 로고    scopus 로고
    • Factors affecting the free plasma fraction of phenytoin in patients with epilepsy
    • DOI 10.2165/00044011-199815020-00008
    • Jiménez MC, et al,. Factors affecting the free plasma fraction of phenytoin in patients with epilepsy. Clin Drug Investig 1998; 15: 153-157. (Pubitemid 28101495)
    • (1998) Clinical Drug Investigation , vol.15 , Issue.2 , pp. 153-157
    • Jimenez, M.C.1    Duran, J.A.2    Abadin, J.A.3
  • 16
    • 0015946877 scopus 로고
    • Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic disease
    • Hooper WD, et al,. Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic disease. Clin Pharmacol Ther 1974; 15: 276-282.
    • (1974) Clin Pharmacol Ther , vol.15 , pp. 276-282
    • Hooper, W.D.1
  • 18
    • 0018386980 scopus 로고
    • Kinetics and metabolism of clobazam in animals and man
    • Volz M, et al,. Kinetics and metabolism of clobazam in animals and man. Br J Clin Pharmacol 1979; 7: 41-50.
    • (1979) Br J Clin Pharmacol , vol.7 , pp. 41-50
    • Volz, M.1
  • 19
    • 0029837135 scopus 로고    scopus 로고
    • Evaluation of unbound serum carbamazepine and carbamazepine-10,11- epoxide concentration prediction methods in polytherapy adult patients with epilepsy
    • Kodama Y, et al,. Evaluation of unbound serum carbamazepine and carbamazepine-10,11-epoxide concentration prediction methods in polytherapy adult patients with epilepsy. Am J Ther 1996; 3: 699-707. (Pubitemid 26405036)
    • (1996) American Journal of Therapeutics , vol.3 , Issue.10 , pp. 699-707
    • Kodama, Y.1    Kuranari, M.2    Fujii, I.3    Kodama, H.4    Takeyama, M.5
  • 20
    • 0022354975 scopus 로고
    • Effect of serum albumin on free fractions of phenobarbital and valproic acid in patients with convulsive seizures
    • Sadahiro N, et al,. Effect of serum albumin on free fractions of phenobarbital and valproic acid in patients with convulsive seizures. Brain Dev 1985; 7: 377-384. (Pubitemid 16247781)
    • (1985) Brain and Development , vol.7 , Issue.4 , pp. 377-384
    • Sadahiro, N.1    Kodama, S.2    Matsui, T.3
  • 21
    • 34247622195 scopus 로고    scopus 로고
    • Carnitine as an antidote for acute valproate toxicity in children
    • DOI 10.1097/MOP.0b013e32805e879a, PII 0000848020070400000016
    • Russell S,. Carnitine as an antidote for acute valproate toxicity in children. Curr Opin Pediatr 2007; 19: 206-210. (Pubitemid 46668075)
    • (2007) Current Opinion in Pediatrics , vol.19 , Issue.2 , pp. 206-210
    • Russell, S.1
  • 22
    • 19544380424 scopus 로고    scopus 로고
    • L-carnitine was safely administered in the setting of valproate toxicity
    • LoVecchio F, et al,. L-carnitine was safely administered in the setting of valproate toxicity. Am J Emerg Med 2005; 23: 321-322.
    • (2005) Am J Emerg Med , vol.23 , pp. 321-322
    • Lovecchio, F.1
  • 24
    • 0026311514 scopus 로고
    • Protein binding of L-carnitine family components
    • Marzo A, et al,. Protein binding of L-carnitine family components. Eur J Drug Metab Pharmacokinet 1991; 3: 364-368.
    • (1991) Eur J Drug Metab Pharmacokinet , vol.3 , pp. 364-368
    • Marzo, A.1
  • 25
    • 38349018462 scopus 로고    scopus 로고
    • Characterization of non-linear relationship between total and unbound serum concentrations of valproic acid in epileptic children
    • Ueshima S, et al,. Characterization of non-linear relationship between total and unbound serum concentrations of valproic acid in epileptic children. J Clin Pharm Ther 2008; 33: 31-38.
    • (2008) J Clin Pharm Ther , vol.33 , pp. 31-38
    • Ueshima, S.1
  • 27
    • 0033337583 scopus 로고    scopus 로고
    • No effect of gender or age on binding characteristics of valproic acid to serum proteins in pediatric patients with epilepsy
    • Kodama Y, et al,. No effect of gender or age on binding characteristics of valproic acid to serum proteins in pediatric patients with epilepsy. J Clin Pharmacol 1999; 39: 1070-1076. (Pubitemid 30641867)
    • (1999) Journal of Clinical Pharmacology , vol.39 , Issue.10 , pp. 1070-1076
    • Kodama, Y.1    Kodama, H.2    Kuranari, M.3    Tsutsumi, K.4    Ono, S.5    Fujimura, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.